Download the Article
Expert Insights with Oncology Expert, Dr. Lyon Gleich
Expert Insights with Oncology Expert, Dr. Lyon Gleich
Liquid Biopsy in Oncology Clinical Trials
Finding biomarkers for solid tumors used to be limited to tissue samples collected with a tissue biopsy. Now, biomarkers obtained from liquid biopsy samples like blood, cerebrospinal fluid or urine may help with cancer treatment selection and monitoring of treatment outcomes.
Explore the dynamic landscape of oncology clinical development in the recent article, “The Utility of Liquid Biopsy in Oncology Clinical Trials,” highlighting insights from the distinguished oncology expert, Dr. Lyon Gleich.
Hematology & Oncology
An integrated Approach
With our proven full-service outsourcing model, Medpace delivers high-quality results. In the competitive field of hematology and oncology, we have earned a reputation for taking on some of the most complex and challenging cancer research studies.
- Global, in-house medical experts across a wide range of therapeutic areas, including hematology and oncology, and global regions, including Asia Pacific, Europe, and the US—demonstrated by 250+ hematology and oncology trials
- Comprehensive regulatory affairs and operational experts who work collaboratively with our medical team
- Expedited start-up and recruitment, including long-term site relationships and preferred CRO status with key Phase I hematology and oncology centers
- Integrated tumor imaging and central laboratory services, ensuring seamless logistics, review, and testing
